Works matching IS 00316970 AND DT 2021 AND VI 77 AND IP 10


Results: 20
    1
    2

    Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.

    Published in:
    2021
    By:
    • Pazan, Farhad;
    • Petrovic, Mirko;
    • Cherubini, Antonio;
    • Onder, Graziano;
    • Cruz-Jentoft, Alfonso J.;
    • Denkinger, Michael;
    • van der Cammen, Tischa J. M.;
    • Stevenson, Jennifer M.;
    • Ibrahim, Kinda;
    • Rajkumar, Chakravarthi;
    • Bakken, Marit Stordal;
    • Baeyens, Jean-Pierre;
    • Crome, Peter;
    • Frühwald, Thomas;
    • Gallaghar, Paul;
    • Guðmundsson, Adalsteinn;
    • Knol, Wilma;
    • O'Mahony, Denis;
    • Pilotto, Alberto;
    • Rönnemaa, Elina
    Publication type:
    Correction Notice
    3
    4
    5
    6
    7
    8

    A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9.

    Published in:
    European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1473, doi. 10.1007/s00228-021-03149-2
    By:
    • Zeitlinger, Markus;
    • Bauer, Martin;
    • Reindl-Schwaighofer, Roman;
    • Stoekenbroek, Robert M.;
    • Lambert, Gilles;
    • Berger-Sieczkowski, Evelyn;
    • Lagler, Heimo;
    • Oesterreicher, Zoe;
    • Wulkersdorfer, Beatrix;
    • Lührs, Petra;
    • Galabova, Gergana;
    • Schwenke, Carsten;
    • Mader, Robert M.;
    • Medori, Rossella;
    • Landlinger, Christine;
    • Kutzelnigg, Alexandra;
    • Staffler, Günther
    Publication type:
    Article
    9
    10

    Comparing the clinical outcomes across different sodium/glucose cotransporter 2 (SGLT2) inhibitors in heart failure patients: a systematic review and network meta-analysis of randomized controlled trials.

    Published in:
    European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1453, doi. 10.1007/s00228-021-03147-4
    By:
    • Teo, Yao Hao;
    • Yoong, Celine Shuen Yin;
    • Syn, Nicholas L.;
    • Teo, Yao Neng;
    • Cheong, Jia Yang Alex;
    • Lim, Yoke-Ching;
    • Lee, Chi-Hang;
    • Yeo, Tiong-Cheng;
    • Chai, Ping;
    • Wong, Raymond C. C.;
    • Lin, Weiqin;
    • Sia, Ching-Hui
    Publication type:
    Article
    11
    12
    13

    Drugs and Dupuytren's disease: a pharmacovigilance study in VigiBase®.

    Published in:
    European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1587, doi. 10.1007/s00228-021-03139-4
    By:
    • Montastruc, Jean-Louis;
    • Guion-Firmin, Julia;
    • de Canecaude, Claire;
    • Ruyssens-Witrand, Adeline;
    • Durrieu, Genevieve;
    • Lafaurie, Margaux;
    • Sommet, Agnès
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    A cross-sectional study of chemotherapy-related AKI.

    Published in:
    European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1503, doi. 10.1007/s00228-021-03115-y
    By:
    • Kang, Xin;
    • Zheng, Xizi;
    • Xu, Damin;
    • Su, Tao;
    • Zhou, Ying;
    • Ji, Jing;
    • Yu, Qi;
    • Cui, Yimin;
    • Yang, Li
    Publication type:
    Article
    20